. . . . . . . "[AITL1 cases, more often than RLH controls, were older [median ages 61 (range 23-79) vs 46 (range 11-59) years, p?<?10(-4)], non-Chinese [16/30 (53%) vs 8/28 (29%), p?=?0.035], presented nodally [29/30 (97%) vs 23/30 (77%), p?=?0.024], showed: pan-T cell antigen attenuation [25/29 (86%) vs 5/21 (24%), p?=?1.0?�?10(-5)], CD4 predominance [25/28 (89%) vs 12/23 (52%), p?=?3.4?�?10(-3)], interfollicular lymphoid CD10-positivity [16/30 (53%) vs 1/29 (3%), p?=?1.5?�?10(-5)], TRG clonality [16/28 (57%) vs 1/20 (5%), p?=?1.4?�?10(-4)], higher maximum number of Epstein-Barr virus-encoded RNA?+?nuclei per 0.5-mm high-power field [median 6 (range 0-70) vs 1 (range 0-40), p?=?0.012] and interfollicular Ki-67 proliferation fraction [median 40% (range 10-80%) vs 20% (range 5-40), p?<?10(-4)], whereas their germinal centres (GCs) more often showed attenuation of CD10 [30/30 (100%) vs 11/29 (38%), p?=?5.3?�?10(-8)] and CD57 [18/25 (72%) vs 4/22 (18%), p?=?2.4?�?10(-4)] (respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:18:21+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .